scholarly journals PMS22 Direct Medical Cost of Osteoporosis in Saudi Arabia: A Single-Center Retrospective Cost Analysis

2020 ◽  
Vol 23 ◽  
pp. S596
Author(s):  
B. Balkhi ◽  
S. Alqusair ◽  
B. Alotaibi ◽  
A. Alghamdi ◽  
Y. AlRuthia ◽  
...  
Author(s):  
Nunik Dewi Kumalasari ◽  
Abdul Rahem ◽  
Bobby Presley ◽  
Eko Setiawan

Long-term treatment of cardiovascular disease may give impact in a high burden of medical cost for the patient. A concern arises whether the health budget allocation prepared by the Indonesian Government through "Jaminan Kesehatan Nasional" program is enough to cover medical cost for the outpatient treatment. This study aims to calculate the direct medical cost of patients with coronary heart disease and heart failure and compare it with the Indonesian Case Base Groups (INA-CBGs) tariff. This is a prospective and observational study carried out in one of the public hospitals in East Java between February and April 2015. All data related to outpatients with coronary heart disease and heart failure were analysed. Direct medical cost analysis in this study calculated from a combination of cost of medication, health professional services, electrocardiography, emergency care services, and laboratory test component, then it was compared with INA-CBGs tariff from ICD 10. Total of 390 patients included were 387 patients with coronary heart disease (99.23%) and three (3) patients with heart failure (0.77%). Average direct medical cost for patients with coronary heart disease and heart failure were IDR 130.593,6 (range IDR 50.282 – IDR 385.911) and IDR 128.587 (range IDR 112.832 – IDR 140.103), respectively. Even though this study showed that budget allocation of INA-CBGs could cover the average direct medical cost of patients with both of diseases, some patients had a direct medical cost higher than the limit of INA-CBGs allocation. Therefore, an optimal interprofessional collaboration between physician and pharmacist needed to provide medical treatment based on patient needs and keep it within budget allocation range.


2021 ◽  
Vol 25 (10) ◽  
pp. 1118-1123
Author(s):  
Shivakumar Iyer ◽  
Kamini N Reddy ◽  
Jignesh Shah ◽  
Monidipa Chowdhury ◽  
Naveen Yerrapalem ◽  
...  

2020 ◽  
Vol 23 ◽  
pp. S435
Author(s):  
A. Alghamdi ◽  
S. Alqahtani

Author(s):  
Bander Balkhi ◽  
Ahmed Alghamdi ◽  
Sulaiman Alqusair ◽  
Bader Alotaibi ◽  
Yazed AlRuthia ◽  
...  

Osteoporosis and its complications are a major health concern in Saudi Arabia, and the prevalence of osteoporosis is on the rise. The aim of this study was to estimate the direct healthcare cost for patients with osteoporosis. A retrospective study was carried out among adult patients with osteoporosis in a teaching hospital in Saudi Arabia. A bottom-up approach was conducted to estimate the healthcare resources used and the total direct medical cost for the treatment of osteoporosis and related fractures. The study included 511 osteoporosis patients, 93% of whom were female. The average (SD) age was 68.5 years (10.2). The total mean direct medical costs for patients without fractures were USD 975.77 per person per year (PPPY), and for those with osteoporotic fractures, the total direct costs were USD 9716.26 PPPY, of which 56% of the costs were attributable to surgery procedures. Prior to fractures, the main cost components were medication, representing 61%, and physician visits, representing 18%. The findings of this study indicated the economic impact of osteoporosis and related fractures. With the aging population in Saudi Arabia, the burden of disease could increase significantly, which highlights the need for effective prevention strategies to minimize the economic burden of osteoporosis.


Author(s):  
Noor N. Junejo ◽  
Santiago Vallasciani ◽  
Ahmad Alshammari ◽  
Hossam Aljallad ◽  
Saeed Alshahrani ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document